A Study of Paliperidone Palmitate 6-Month Formulation

NCT04072575 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

178

Enrollment

INDUSTRY

Sponsor class

Conditions

Schizophrenia

Interventions

DRUG: PP6M injection Dose 1
DRUG: PP6M injection Dose 2

Sponsor

Janssen Research & Development, LLC